Zacks.com featured highlights include AES, BorgWarner, Enersys, PG&E and Keros Therapeutics [Yahoo! Finance]
Keros Therapeutics, Inc. - common stock (KROS)
Company Research
Source: Yahoo! Finance
5 Low Price-to-Book Stocks to Buy as 2025 Comes to a Close Value investors have, over the years, preferred the price-to-earnings ratio or P/E, as a means to identify value stocks. However, in the case of loss-making companies that have a negative price-to-earnings ratio, the price-to-sales or P/S ratio is considered in determining their true value. However, the price-to-book ratio (P/B ratio), though used less often, is also an easy-to-use valuation tool for identifying low-priced stocks with great returns. The P/B ratio is calculated as below: P/B ratio = market capitalization/book value of equity The P/B ratio helps identify low-priced stocks with high growth prospects. Here we discuss five stocks with a low P/B ratio and a “Buy” recommendation as 2025 comes to a close. The AES Corporation BorgWarner Enersys PG&E Corporation and Keros Therapeutics are some such stocks. Now, let us understand the concept of book value. What is Book Value? There are several ways in wh
Show less
Read more
Impact Snapshot
Event Time:
KROS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KROS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KROS alerts
High impacting Keros Therapeutics, Inc. - common stock news events
Weekly update
A roundup of the hottest topics
KROS
News
- Keros Therapeutics (NASDAQ:KROS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- KROS or ARGX: Which Is the Better Value Stock Right Now? [Yahoo! Finance]Yahoo! Finance
- Keros Therapeutics (NASDAQ:KROS) was upgraded by analysts at TD Cowen to a "hold" rating.MarketBeat
- KROS vs. ARGX: Which Stock Is the Better Value Option? [Yahoo! Finance]Yahoo! Finance
- Keros Therapeutics (NASDAQ:KROS) had its price target raised by analysts at Bank of America Corporation from $18.00 to $19.00. They now have a "neutral" rating on the stock.MarketBeat
KROS
Earnings
- 11/5/25 - Beat
KROS
Sec Filings
- 1/9/26 - Form 8-K
- 1/9/26 - Form 4
- 12/18/25 - Form 4
- KROS's page on the SEC website